Drugs / DCIK
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01240005 | Jan 2011 → Dec 2012 | renal cell carcinoma | Qingdao University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DCIK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01240005 ↗ |
| Modality | Cell therapy | “DC activated CIK cells” NCT01240005 ↗ |
| Route | Intravenous | “three intravenous infusions of DC activated CIK cells at 1-day intervals” NCT01240005 ↗ |